Skip to main content

CASTLE BIOSCIENCES INC

For the period ended Nov 4, 2024. Filed Nov 4, 2024.

View on SEC.gov

About this filing

A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.

Nov 4, 2024 · Filed Nov 4, 2024

Use the contents to explore the available documents and sections.

CSTL$32.52-4.9%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits

EX-99.1 · (in thousands, except per share data)

(in thousands, except per share data)

Three Months EndedSeptember 30,Nine Months EndedSeptember 30,
2024202320242023
NET REVENUES$85,782$61,493$245,758$153,668
OPERATING EXPENSES
Cost of sales (exclusive of amortization of acquired intangible asset)15,60911,31944,02232,559
Research and development12,32312,92340,26840,624
Selling, general and administrative50,49944,619150,082136,062
Amortization of acquired intangible asset2,2722,2726,7666,742
Total operating expenses, net80,70371,133241,138215,987
Operating income (loss)5,079(9,640)4,620(62,319)
Interest income3,4042,7699,5447,504
Interest expense(201)(2)(485)(9)
Income (loss) before income taxes8,282(6,873)13,679(54,824)
Income tax expense6,013325,02462
Net income (loss)$2,269$(6,905)$8,655$(54,886)
Earnings (loss) per share:
Basic$0.08$(0.26)$0.31$(2.05)
Diluted$0.08$(0.26)$0.30$(2.05)
Weighted-average shares outstanding:
Basic27,84026,83427,65926,725
Diluted29,40126,83428,83826,725
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.